Search
for
Sort by
Research 121–150 of 1000+
- Stress Inhibits Hair Growth in Mice by Induction of Premature Catagen Development and Deleterious Perifollicular Inflammatory Events via Neuropeptide Substance P-Dependent Pathways
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
- Upadacitinib for the Management of Alopecia Totalis and Subtotalis in Pediatric Patients: A Case Series
- Myasthenia Gravis Coexisting With Primary Sjögren's Syndrome: Report of Three Cases and Literature Review
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review
- Drug Repurposing Patent Applications April–June 2021
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Minoxidil downregulates Interleukin-1 alpha gene expression in HaCaT cells
- Recombinant Human Annexin A5 Ameliorates Localized Scleroderma by Inhibiting the Activation of Fibroblasts and Macrophages
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- Molecular Targets in Modern Cosmetic Science
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Das weiße Hautfettgewebe initiiert die IL-33-abhängige Expression von Interleukin 4/13 in myeloischen Zellen während einer Entzündung
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- JAK inhibitors and alopecia areata
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- Protective role of agomelatine via modulation of TLR4/NF-κB: NLRP3/IL-1β signaling pathways in testosterone-induced benign prostatic hyperplasia in rats
- A functional polymorphism in interleukin-1α (IL1A) gene is associated with risk of alopecia areata in Chinese populations
- Targeting lymphoid-derived IL-17 signaling to delay skin aging
- Chapter 17. Selective androgen receptor modulators (SARMs)
- A Cell Membrane-Level Approach to Cicatricial Alopecia Management: Is Caveolin-1 a Viable Therapeutic Target in Frontal Fibrosing Alopecia?
- The Association Between 5α-Reductase Inhibitors and the Presence of Subsequent Dry Eye Disease in Androgenetic Alopecia: A TriNetX Database Study
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Efficacy of Janus kinase inhibitors in adult patients with alopecia areata
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Keratin 17 modulates hair follicle cycling in a TN<i>Fα</i>-dependent fashion
- Mast cell deficient and neurokinin-1 receptor knockout mice are protected from stress-induced hair growth inhibition